GPC Biotech to Cut 103 Jobs in Germany, U.S.

GPC Biotech, which recently reported that its prostate cancer drug satraplatin didn’t meet its intended goal, said it’s cutting 44 percent of its workforce, with 60 jobs lost in Munich and another 43 in Princeton.
MarketWatch